Cheaper than your copayment? You can pay that instead.
The bill requires every pharmacy to tell a patient the lowest cash price it charges for the drug or biological product the patient was prescribed. If that price is lower than the patient's insurance copayment, the pharmacist must offer the patient the choice to pay the lower price instead. Pharmacies and pharmacists in Texas must do this starting September 1, 2025, so patients can see when skipping their insurance would cost them less.
Labels
Labels: ZOMBIE BILL. Died 2 times: 88R SB 2212 (Died in committee) and this bill (Did not pass). Checked against 88R only.DO-OVER. Reworked text of a bill filed before that died: 88R SB 2212 (Died in committee). Filed in 2 sessions, counting this one. Checked against 88R only.TRY NO. 2. Filed in 2 sessions: 88R and 89R. Checked against 88R only.CROSS-PARTY HANDOFF. Lead author César Blanco (D) in the Senate. Lead sponsor Lacey Hull (R) in the House. Party as the Legislative Reference Library lists it for the 89th Legislature.GOT HALFWAY. Passed the Senate on Apr 3, 2025. Died in the House: voted out of the Public Health committee 10-0, no floor vote.
relating to the disclosure by a pharmacy to a patient of certain
price information for a drug or biological product.
WHAT IT DOES
Cheaper than your copayment? You can pay that instead.
The bill requires every pharmacy to tell a patient the lowest cash price it charges for the drug or biological product the patient was prescribed. If that price is lower than the patient's insurance copayment, the pharmacist must offer the patient the choice to pay the lower price instead. Pharmacies and pharmacists in Texas must do this starting September 1, 2025, so patients can see when skipping their insurance would cost them less.
CHARGES
[ ] NONE FOUND
TOTAL
No significant fiscal implication to the State is anticipated.
Names were not printed. No individual positions are inferred.
Sources
Senator Blanco moved that Senate Rule 7.18 and the Constitutional Rule requiring bills to be read on three several days be suspended and that SB 1098 be placed on its third reading and final passage. The motion prevailed by the following vote: Yeas 31, Nays 0. The bill was read third time and was passed by the following vote: Yeas 31, Nays 0.
Published stock of positions for this vote, except where marked derived.
Yea: 31 (published)
Nay: 0 (published)
Present, not voting: Not printed
Absent: Not printed
Excused: Not printed
Senate journal. Source snapshot 2026-10-19, Central time.
Names were not printed. No individual positions are inferred.
Sources
Senator Blanco moved that Senate Rule 7.18 and the Constitutional Rule requiring bills to be read on three several days be suspended and that SB 1098 be placed on its third reading and final passage. The motion prevailed by the following vote: Yeas 31, Nays 0.
Published stock of positions for this vote, except where marked derived.
Yea: 31 (published)
Nay: 0 (published)
Present, not voting: Not printed
Absent: Not printed
Excused: Not printed
Senate journal. Source snapshot 2026-10-19, Central time.
House committee · Public Health · Committee vote 10 aye, 0 nay, 3 absent · Out of committee
Senate committee · Health & Human Services · Committee vote 9 aye, 0 nay · Out of committee
Subjects
Consumer Protection
Insurance--Health & Accident
Occupational Regulation--Health Occupations
MEDICINE & PRESCRIPTION DRUGS
PHARMACIES & PHARMACISTS
Text
The text as introduced · 153 words
89R8582 JTZ-D
By: Blanco
S.B. No. 1098
A BILL TO BE ENTITLED
AN ACT
relating to the disclosure by a pharmacy to a patient of certain
price information for a drug or biological product.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Section 562.003, Occupations Code, is amended to
read as follows:
Sec. 562.003. DISCLOSURE OF PRICE; PATIENT'S OPTION. (a) A
pharmacy shall disclose the lowest cost cash price at that pharmacy
for the drug or biological product prescribed to the patient.
(b) If the price of a drug or biological product to a patient
is lower than the amount of the patient's copayment under the
patient's prescription drug insurance plan, the pharmacist shall
offer the patient the option of paying for the drug or biological
product at the lower price instead of paying the amount of the
copayment.
SECTION 2. This Act takes effect September 1, 2025.
Monitoring 
